Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02412220

Ligand	Ligand name	Chain	PDB	Tanimoto
FKA	BENZYL-CARBAMIC ACID [8-DEETHYL-ASCOMYCIN-8-YL]ETHYL ESTER	B	1A7X	0.7
NBY	N-{[(4-nitrophenyl)carbonyl]carbamoyl}-beta-D-glucopyranosylamine	A	2QN8	0.71
BND	ME-A-N-BENZOYL-AMINO-9-DEOXY-NEU5AC	A	1OD9	0.89
SP8	N-{(1S)-3-[(4-aminobutyl)amino]-1-methylpropyl}benzamide	A,B	3CNS	0.7
EJT	1,3-DI(N-PROPYLOXY-A-MANNOPYRANOSYL)-CARBOMYL 5-METHYAZIDO-BENZENE	A,B	1QGL	0.81
BFN	5-(acetylamino)-2,6-anhydro-3,5,9-trideoxy-3-fluoro-9-[(phenylcarbonyl)amino]-D-arabino-L-galacto-nononic acid	A	3B69	0.85
C90	N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide	A	2JT2	0.71
YC2	N-{[(1S)-1-carboxy-5-{[(4-iodophenyl)carbonyl]amino}pentyl]carbamoyl}-L-glutamic acid	A	3D7H	0.73
KHA	1-(4-{[(2-HYDROXYETHYL)AMINO]CARBONYL}BENZYL)-1-METHYLPIPERIDINIUM	H,L,X,Y	1UWG	0.73
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B,C,D	1SN9	0.71
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B	1SNE	0.71
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B,C,D	1SNA	0.71
DBZ	3-(BENZOYLAMINO)-L-ALANINE	A,B	1XOF	0.71
B17	{1-[4-(AMINOSULFONYL)PHENYL]-11-[(CARBOXY-KAPPAO)METHYL]-1-OXO-5,8-DIOXA-2,11-DIAZATRIDECAN-13-OATO(2-)-KAPPAO~13~}COPPER	A	2FOS	0.71
NBX	N-{[(4-aminophenyl)carbonyl]carbamoyl}-beta-D-glucopyranosylamine	A	2QN9	0.74
AI1	N-BENZYL-3-(ALPHA-D-GALACTOS-1-YL)-BENZAMIDE	D,E,F,G,H,L,M,N,O,P	1FD7	0.72
DPC	5-ACETYLAMINO-4-AMINO-6-(PHENETHYL-PROPYL-CARBAMOYL)-5,6-DIHYDRO-4H-PYRAN-2-CARBOXYLIC ACID	A,B	1A4Q	0.7
DPC	5-ACETYLAMINO-4-AMINO-6-(PHENETHYL-PROPYL-CARBAMOYL)-5,6-DIHYDRO-4H-PYRAN-2-CARBOXYLIC ACID	A	1BJI	0.7
BDU	ME-A-9-N-(BIPHENYL-4-CARBONYL)-AMINO-9-DEOXY-NEU5AC	A	1ODA	0.86
HOP	(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL	H,L	1D6V	0.71
HOP	(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL	A,B,H,L	1AXS	0.71
OTG	ORTHO-TOLUOYLGLUCOSAMINE	A	2YHX	0.9
LHA	DOUBLY FUNCTIONALIZED PAROMOMYCIN PM-II-162	A,B	2PWT	0.76
NDL	N-BENZOYL-L-NORLEUCYL-L-LYSYL-L-ARGINYL-L-ARGININE	B	2FP7	0.7
KAF	N-{(5S)-4,4-dihydroxy-6-phenyl-5-[(phenylcarbonyl)amino]hexanoyl}-L-phenylalanine	A	3BKK	0.72
ICX	methyl N-[(5Z)-6-({[4-(4-iodobenzyl)phenyl]carbonyl}amino)hex-5-enoyl]glycinate	A,C,D,E,G,P,Q,R,W	3CWB	0.72
SC7	N'-{(1S,2R)-1-(3,5-DIFLUOROBENZYL)-2-[(2R,4S)-4-ETHOXYPIPERIDIN-2-YL]-2-HYDROXYETHYL}-5-METHYL-N,N-DIPROPYLISOPHTHALAMIDE	A,B	2QP8	0.75
ARQ	BENZOYLAMINO-BENZYL-METHYL-[2-HYDROXY-3-[1-METHYL-ETHYL-OXY-N-FORMAMIDYL]-4-PHENYL-BUTYL]-AMMONIUM	A	3AID	0.71
BZD		A	1K06	0.79
BZD		A	1K08	0.79
BZD		A	2QNB	0.79
F68	N-{[(4-methylphenyl)carbonyl]carbamoyl}-beta-D-glucopyranosylamine	A	2QLM	0.79
PH5	2-PHENYL-PROP5AC	A,B	2BVE	0.78
MNI	N-{[(2R,3R,4R,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)PYRROLIDIN-2-YL]METHYL}-4-(DIMETHYLAMINO)BENZAMIDE	A,B	2OYM	0.71
B1L	3-[(4-HYDROXYBENZOYL)AMINO]AZEPAN-4-YL 4-HYDROXYBENZOATE	A	1REJ	0.73
EG2	AMINODI(ETHYLOXY)ETHYLAMINOCARBONYLBENZENESULFONAMIDE	A	1CNX	0.7
F59	N-[(biphenyl-4-ylcarbonyl)carbamoyl]-beta-D-glucopyranosylamine	A	2QLN	0.76
S2D	N-BENZOYL-D-ALANINE	A,B	2JCI	0.73
SUW	ME-A-9-N-(NAPHTHYL-2-CARBONYL)-AMINO-9-DEOXY-NEU5AC	A	1OD7	0.83
SEI	1-{3-METHYL-2-[4-(MORPHOLINE-4-CARBONYL)-BENZOYLAMINO]-BUTYRYL}-PYRROLIDINE-2-CARBOXYLIC ACID (3,3,4,4,4-PENTAFLUORO-1-ISOPROPYL-2-OXO-BUTYL)-AMIDE	A	1B0F	0.71
SEI	1-{3-METHYL-2-[4-(MORPHOLINE-4-CARBONYL)-BENZOYLAMINO]-BUTYRYL}-PYRROLIDINE-2-CARBOXYLIC ACID (3,3,4,4,4-PENTAFLUORO-1-ISOPROPYL-2-OXO-BUTYL)-AMIDE	A	1B0E	0.71
SP9	N-{(1R)-3-[(4-aminobutyl)amino]-1-methylpropyl}benzamide	A,B	3CNT	0.7
HBZ	N-{[(4-hydroxyphenyl)carbonyl]carbamoyl}-beta-D-glucopyranosylamine	A	2QN7	0.71
F55	N-{[(4-chlorophenyl)carbonyl]carbamoyl}-beta-D-glucopyranosylamine	A	2QN3	0.74
485	[2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]- (3,4,5-TRIHYDROXY-6-METHYL-TETRAHYDRO-PYRAN-2-YL)- ACETIC ACID	A	1JIL	0.71